These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26403146)

  • 1. Power and sample size in clinical studies.
    Brown TM
    J Nucl Cardiol; 2015 Dec; 22(6):1314-5. PubMed ID: 26403146
    [No Abstract]   [Full Text] [Related]  

  • 2. Power analysis and sample size calculation.
    Bagiella E; Chang H
    J Mol Cell Cardiol; 2019 Aug; 133():214-216. PubMed ID: 30639699
    [No Abstract]   [Full Text] [Related]  

  • 3. Translational clinical trials: an entropy-based approach to sample size.
    Piantadosi S
    Clin Trials; 2005; 2(2):182-92. PubMed ID: 16279140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size and power: how big is big enough?
    Fitzmaurice G
    Nutrition; 2002 Mar; 18(3):289-90. PubMed ID: 11882410
    [No Abstract]   [Full Text] [Related]  

  • 5. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caution regarding the use of pilot studies to guide power calculations for study proposals.
    Kraemer HC; Mintz J; Noda A; Tinklenberg J; Yesavage JA
    Arch Gen Psychiatry; 2006 May; 63(5):484-9. PubMed ID: 16651505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the adaptive performance of flexible sample size designs with treatment difference in an interval.
    Liu GF; Zhu GR; Cui L
    Stat Med; 2008 Feb; 27(4):584-96. PubMed ID: 17634972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patients are the primary source and the target of clinical research.
    Knottnerus JA; Tugwell P; Tricco AC
    J Clin Epidemiol; 2016 Aug; 76():1-3. PubMed ID: 27670675
    [No Abstract]   [Full Text] [Related]  

  • 10. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study design in clinical research: sample size estimation and power analysis.
    Lerman J
    Can J Anaesth; 1996 Feb; 43(2):184-91. PubMed ID: 8825545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size determination in group-sequential clinical trials with two co-primary endpoints.
    Asakura K; Hamasaki T; Sugimoto T; Hayashi K; Evans SR; Sozu T
    Stat Med; 2014 Jul; 33(17):2897-913. PubMed ID: 24676799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculations in clinical research should also be based on ethical principles.
    Cesana BM; Antonelli P
    Trials; 2016 Mar; 17(1):149. PubMed ID: 26993625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the efficiency of adaptive sample size design.
    Cui L; Zhang L
    Stat Med; 2019 Mar; 38(6):933-944. PubMed ID: 30450621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power and sample size.
    Case LD; Ambrosius WT
    Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research].
    Kutschmann M; Bender R; Grouven U; Berg G
    Rehabilitation (Stuttg); 2006 Dec; 45(6):377-84. PubMed ID: 17123220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sample size and power analyses in clinical trials].
    Pripp AH
    Tidsskr Nor Laegeforen; 2017 Sep; 137(17):. PubMed ID: 28925211
    [No Abstract]   [Full Text] [Related]  

  • 18. Should minimization replace randomization in all clinical trials?
    Tugwell P; Knottnerus JA; Idzerda L
    J Clin Epidemiol; 2012 Jan; 65(1):1-2. PubMed ID: 22083018
    [No Abstract]   [Full Text] [Related]  

  • 19. Simplification or simulation: Power calculation in clinical trials.
    Huang C; Li P; Martin CR
    Contemp Clin Trials; 2022 Feb; 113():106663. PubMed ID: 34958933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.